Medicare Costs Rise: Retirees Face Higher Premiums

Medicare beneficiaries are expressing growing dissatisfaction with their health insurance coverage and expenses. In 2027, costs are expected to increase further due to rising prescription drug premiums. A significant federal subsidy that previously reduced stand-alone drug plan premiums by an average of $16 per month will expire this year.

Surveys indicate that a substantial percentage of Medicare beneficiaries are unhappy with their coverage, citing high premiums and out-of-pocket costs as primary concerns. Many retirees, living on fixed incomes, are finding that Medicare costs are rising faster than their Social Security benefits, which are projected to increase by only 3.6% in 2027. The standard premium for Medicare Part B already saw a notable increase in 2026, with further modest rises projected.

In addition to premium increases, the out-of-pocket cap for Medicare Part D prescription drug spending is slated to rise to $2,400 in 2027. While a cap on drug spending was introduced in 2025, helping to lower self-reported costs for some, the expiration of subsidies and rising caps are expected to create new financial pressures. Seniors are advised to review their coverage options before the open enrollment period concludes on December 7th.